Siemens Healthineers is cutting back on surgical robotics program

The CorPath system. [Image from Siemens Healthineers Endovascular Robotics/Corindus]Siemens Healthineers said today that it plans to discontinue the use of its Corindus surgical robotics for cardiology procedures.

On the company’s first-quarter earnings call, first reported by Reuters, CFO Jochen Schmitz confirmed the strategy shift. He said the “use of Corindus robots for cardiology operations did not fulfill our expectations.” Schmitz reportedly added that the timeline for robots for neurological operations to reach the market constitutes “several years.”

In 2019, Siemens Healthineers bought out Corindus for $1.1 billion. Corindus develops the CorPath robot-assisted device for coronary and peripheral vascular procedures.

The business arm aims to provide innovative, image-guided robotic solutions. Its CorPath GRX system supports endovascular procedures.

It officially rebranded to “Siemens Healthineers Endovascular Robot…

Read more
  • 0

Corindus rebrands as Siemens Healthineers Endovascular Robotics

The CorPath system. [Image from Siemens Healthineers Endovascular Robotics/Corindus]Siemens Healthineers announced that its Corindus company rebranded to “Siemens Healthineers Endovascular Robotics.”

In 2019, Siemens Healthineers bought out Corindus for $1.1 billion. Corindus develops the CorPath robot-assisted device for coronary and peripheral vascular procedures.

According to a news release, brand unification represents “the final step” in the company integration process that began in 2019. The business aims to advance interventions with robotics, changing the delivery of care through innovations. These innovations enhance physician techniques and bring precision to interventional procedures, Siemens said.

Siemens said it now offers the Endovascular Robotics business access to its company-wide resources. That allows it to continue advancing its vision of developing innovative, image-guided robotic solutions. It intends to continue…

Read more
  • 0

Corindus announces positive study results for CorPath neurovascular system

[Image from Corindus] Corindus today announced positive results from a study of its CorPath used in robotic-assisted neurovascular aneurysm embolization. The Siemens Healthineers company, which develops precision vascular robotics, presented results from a first-of-its-kind study demonstrating the safety and effectiveness of robotic-assisted neurovascular aneurysm embolization using the CorPath GRX neurovascular system. Newton, Massachusetts-based Corindus said the study is the world’s first trial on robotic-assisted neurovascular aneurysm embolization. Dr. Michel Piotin, principal investigator and head of the interventional neuroradiology department at the Rothschild Foundation Hospital in Paris, presented results at the European Society of Minimally Invasive Neurological Therapy (ESMINT) Congress in Nice, France. It was a prospective, single-arm, international, multi-center, non-inferiority study. CorPath GRX demonstrated 94% technical success. Corindus said it a…
Read more
  • 0

16 surgical robotics companies you need to know

Intuitive remains the dominant surgical robotics company, but corporations ranging from Medtronic to Vicarious Surgical look to compete. The Da Vinci Xi robotic surgery system. Intuitive continues to dominate the space. [Image courtesy of Intuitive]Robotic-assisted surgery remains one of the hottest spaces in medtech. Intuitive, which pioneered the field in the 1990s and early 2000s, continues to innovate. At the same time, a host of other companies are looking to compete.

Companies making headlines in the robotic surgery space over the past year include:

Company Robotic system(s) Intuitive Surgical Da Vinci Xi, Da Vinci X, Da Vinci SP, Ion Medtronic Hugo Johnson & Johnson Monarch, Velys, Ottava Stryker Mako Siemens Healthineers’ Corindus CorPath GRX Vicarious Surgical Beta 2 Titan Medical Enos Asensus Surgical Senhance Moon Surgical Maestro Momentus Surgical Anovo Virtual Incision MIRA Stereotaxis Genesis RMN, Vdrive, Niobe Monteris …
Read more
  • 0

Corindus opens new HQ; take a photo tour of the facility

The new Corindus headquarters has a cleanroom that is three times larger than the previous headquarters. [Photo courtesy of Corindus]Corindus announced the opening of its new headquarters this week, moving to Newton, Massachusetts, for a space that’s more than twice as big.

The precision vascular robotics developer’s new facility totals 77,000 ft², compared to 35,000 ft² in the former headquarters in Walham, Massachusetts.

The production area alone is tripling in size to 25,000 ft² and was designed to facilitate the flow of materials through the building. The 6,000 ft² R&D space is also three times larger than the previous headquarters, including a dedicated lab for remote robotic R&D activities and a model shop for quicker prototype machining and shorter development timelines.

The new headquarters will also serve as the global Center of Excellence for Siemens Healthineers endovascular robotic technologies, including development, manufac…

Read more
  • 0

Corindus opens new HQ; take a photo tour of the facility

The new Corindus headquarters has a cleanroom that is three times larger than the previous headquarters. [Photo courtesy of Corindus]

Corindus announced the opening of its new headquarters this week, moving to Newton, Massachusetts, for a space that’s more than twice as big.

The precision vascular robotics developer’s new facility totals 77,000 ft², compared to 35,000 ft² in the former headquarters in Walham, Massachusetts.

The production area alone is tripling in size to 25,000 ft² and was designed to facilitate the flow of materials through the building. The 6,000 ft² R&D space is also three times larger than the previous headquarters, including a dedicated lab for remote robotic R&D activities and a model shop for quicker prototype machining and shorter development timelines.

The new headquarters will also serve as the global Center of Excellence for Siemens Healthineers end…

Read more
  • 0

DTW Podcast: Earnhardt shares how Abbott shifted gears to counter pandemic; Grail still looks to upend oncology

Abbott’s medical devices EVP Lisa Earnhardt discusses the life science giant’s pivot during the COVID-19 pandemic.

In this week’s DeviceTalks Weekly Podcast, Abbott’s medical devices EVP Lisa Earnhardt explains how the life sciences giant pivoted during the pandemic. Earnhardt shares what programs were given greater priority when the lockdown’s impact became clear and why the company performed so well in one of its key businesses.

We also explore this week’s news that the FTC will oppose Illumina’s acquisition of Grail through interviews with Dr. Christopher Keir, vice president of medical affairs at Grail, and Vijay Kumar, senior managing director at Evercore ISI.

And, of course, Chris Newmarker, executive editor of MassDevice, delivers this week’s Newmarker’s Newsmakers, including news from Illumina, Grail, Corindus, Zimmer Biomet, BD, Medtronic and Abbott.

Final…

Read more
  • 0

DTW Podcast: Earnhardt shares how Abbott shifted gears to counter pandemic; Grail still looks to upend oncology

This week, we’ll talk with Lisa Earnhardt, executive vice president, medical devices at Abbott about how the life sciences giant pivoted during the pandemic.

This week, we’ll talk with Lisa Earnhardt, executive vice president, medical devices at Abbott about how the life sciences giant pivoted during the pandemic.

Earnhardt shares what programs were given greater priority when the impact of the lockdown became clear and why the company performed so well in one of its key businesses.

We also explore this week’s news that the FTC will oppose Illumina’s acquisition of Grail.

First, we talk with Dr. Christopher Keir, vice president of medical affairs at Grail, about the great potential of the company’s diagnostic technologies. The interview was recorded last month prior to the FTC’s decision.

Then we talk to Vijay Kumar, senior managing director at Evercore ISI, about why the FTC is making a strong case to block the deal.

And, of course, Chris …

Read more
  • 0

How 5G could affect medtech

The latest standard of broadband technology continues to make waves in 2021. But what about medtech?

 

Cellphone using 5G

Cellphone using 5G (Imagy by Frederik Lipfert on Unsplash)

Wireless tech companies such as Qualcomm are predicting download speeds as high as 10 gigabits per second as next-generation 5G cellular networks roll out worldwide.

The open question in medtech is how quickly companies will take advantage of the super-speedy connectivity for their own products.

“5G is about bringing more capacity and speed to the pipes,” said Don Jones, a member of the advisory council at BrightInsight and a veteran of the digital healthcare space. Jones spent more than 11 years building Qualcomm’s healthcare group.

“What you have to analyze is, ‘Can healthcare take advantage of what essentially amounts to these bigger pipes?’ Because more data can be shoved through them with m…

Read more
  • 0